Quick Answer
PharmaCyte Biotech, Inc. reported Total Assets of $55.17 million for fiscal year 2025.
PharmaCyte Biotech, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $55.17M | -7.9% |
| 2024 | $59.90M | -18.3% |
| 2023 | $73.28M | -19.1% |
| 2022 | $90.62M | +1124.0% |
| 2021 | $7.40M | +20.1% |
| 2020 | $6.17M | +6.6% |
| 2019 | $5.78M | -9.8% |
| 2018 | $6.41M | -26.0% |
| 2017 | $8.67M | +21.0% |
| 2016 | $7.16M | -23.0% |
| 2015 | $9.30M | -0.2% |
| 2014 | $9.32M | +223.8% |
| 2013 | $2.88M | +37.8% |
| 2012 | $2.09M | +68.3% |
| 2011 | $1.24M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $55.87M | +27.5% | -0.2% |
| October 31, 2025 | $55.98M | +1.6% | +24.1% |
| July 31, 2025 | $45.11M | -35.7% | -18.2% |
| April 30, 2025 | $55.17M | -7.9% | +25.9% |
| January 31, 2025 | $43.83M | -38.6% | -20.5% |
| October 31, 2024 | $55.10M | -30.1% | -21.5% |
| July 31, 2024 | $70.19M | -12.1% | +17.2% |
| April 30, 2024 | $59.90M | -18.3% | -16.1% |
- PharmaCyte Biotech, Inc. showed a decrease of -7.9% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, PharmaCyte Biotech, Inc.’s total assets has grown by 4348.4% (from $1.24 million to $55.17 million).
- The most recent figure is from PharmaCyte Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 11, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: